Myeloid derived suppressor cells in transplantation

Current Opinion in Immunology

Volumn 23, Issue 5, 2011, Pages 692-697

  Lees, Jason R ^a   Azimzadeh, Agnes M ^a   Bromberg, Jonathan S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CHEMOKINE; COMPLEMENT COMPONENT C5A; CYTOKINE; GROWTH FACTOR; PROSTAGLANDIN E2;

ANTIGEN SPECIFICITY; B LYMPHOCYTE; CELL ACTIVATION; CYTOKINE RELEASE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PHENOTYPE; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS; CELL LINEAGE; CELL PROLIFERATION; CYTOKINES; GRAFT REJECTION; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSION; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; MYELOID PROGENITOR CELLS; NEOPLASMS; ORGAN TRANSPLANTATION;

EID: 80053613350     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.07.004     Document Type: Review

References (41)

1. Almand B., Clark J.I., Nikitina E., van Beynen J., English N.R., Knight S.C., Carbone D.P., Gabrilovich D.I. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001, 166:678-689.
2. Bronte V., Apolloni E., Cabrelle A., Ronca R., Serafini P., Zamboni P., Restifo N.P., Zanovello P. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 2000, 96:3838-3846.
3. Mandruzzato S., Solito S., Falisi E., Francescato S., Chiarion-Sileni V., Mocellin S., Zanon A., Rossi C.R., Nitti D., Bronte V., et al. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. J Immunol 2009, 182:6562-6568.
4. Movahedi K., Guilliams M., Van den Bossche J., Van den Bergh R., Gysemans C., Beschin A., De Baetselier P., Van Ginderachter J.A. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008, 111:4233-4244.
5. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008, 181:5791-5802.
6. Haile L.A., Gamrekelashvili J., Manns M.P., Korangy F., Greten T.F. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice. J Immunol 2010, 185:203-210.
7. Yang R., Cai Z., Zhang Y., Yutzy WHt., Roby K.F., Roden R.B. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+ CD11b+ myeloid cells. Cancer Res 2006, 66:6807-6815.
8. Pan P.Y., Ma G., Weber K.J., Ozao-Choy J., Wang G., Yin B., Divino C.M., Chen S.H. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 2010, 70:99-108.
9. Dugast A.S., Haudebourg T., Coulon F., Heslan M., Haspot F., Poirier N., Vuillefroy de Silly R., Usal C., Smit H., Martinet B., et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 2008, 180:7898-7906.
10. Bronte V., Wang M., Overwijk W.W., Surman D.R., Pericle F., Rosenberg S.A., Restifo N.P. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J Immunol 1998, 161:5313-5320.
11. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
12. De Wilde V., Van Rompaey N., Hill M., Lebrun J.F., Lemaitre P., Lhomme F., Kubjak C., Vokaer B., Oldenhove G., Charbonnier L.M., et al. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 2009, 9:2034-2047.
13. Li H., Han Y., Guo Q., Zhang M., Cao X. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 2009, 182:240-249.
14. Bogdan C. Regulation of lymphocytes by nitric oxide. Methods Mol Biol 2011, 677:375-393.
15. Rodriguez P.C., Zea A.H., Culotta K.S., Zabaleta J., Ochoa J.B., Ochoa A.C. Regulation of T cell receptor CD3zeta chain expression by l-arginine. J Biol Chem 2002, 277:21123-21129.
16. Rodriguez P.C., Quiceno D.G., Ochoa A.C. l-Arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007, 109:1568-1573.
17. Srivastava M.K., Sinha P., Clements V.K., Rodriguez P., Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 2010, 70:68-77.
18. Corzo C.A., Cotter M.J., Cheng P., Cheng F., Kusmartsev S., Sotomayor E., Padhya T., McCaffrey T.V., McCaffrey J.C., Gabrilovich D.I. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 2009, 182:5693-5701.
19. Nagaraj S., Gupta K., Pisarev V., Kinarsky L., Sherman S., Kang L., Herber D.L., Schneck J., Gabrilovich D.I. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007, 13:828-835.
20. Ezernitchi A.V., Vaknin I., Cohen-Daniel L., Levy O., Manaster E., Halabi A., Pikarsky E., Shapira L., Baniyash M. TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J Immunol 2006, 177:4763-4772.
21. Huang B., Pan P.Y., Li Q., Sato A.I., Levy D.E., Bromberg J., Divino C.M., Chen S.H. Gr-1+ CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006, 66:1123-1131.
22. Garcia M.R., Ledgerwood L., Yang Y., Xu J., Lal G., Burrell B., Ma G., Hashimoto D., Li Y., Boros P., et al. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 2010, 120:2486-2496.
23. Sinha P., Clements V.K., Bunt S.K., Albelda S.M., Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007, 179:977-983.
24. Gallina G., Dolcetti L., Serafini P., De Santo C., Marigo I., Colombo M.P., Basso G., Brombacher F., Borrello I., Zanovello P., et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006, 116:2777-2790.
25. Cheng P., Corzo C.A., Luetteke N., Yu B., Nagaraj S., Bui M.M., Ortiz M., Nacken W., Sorg C., Vogl T., et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008, 205:2235-2249.
26. Greifenberg V., Ribechini E., Rossner S., Lutz M.B. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur J Immunol 2009, 39:2865-2876.
27. Shojaei F., Zhong C., Wu X., Yu L., Ferrara N. Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 2008, 18:372-378.
28. Makarenkova V.P., Bansal V., Matta B.M., Perez L.A., Ochoa J.B. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006, 176:2085-2094.
29. Zhang W., Liang S., Wu J., Horuzsko A. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+ Gr1+myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 2008, 86:1125-1134.
30. Hock BD, Mackenzie KA, Cross NB, Taylor KG, Currie MJ, Robinson BA, Simcock JW, McKenzie JL: Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells. Nephrol Dial Transplant 2011 [Epub ahead of print]. The first report showing increased systemic MDSC frequency and MDSC/DC ratio in kidney allograft recipients with cutaneous squamous cell carcinoma.
31. Solito S., Bronte V., Mandruzzato S. Antigen specificity of immune suppression by myeloid-derived suppressor cells. J Leukoc Biol 2011, 90:31-36.
32. Ostrand-Rosenberg S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother 2010, 59:1593-1600.
33. Dilek N., van Rompaey N., Le Moine A., Vanhove B. Myeloid-derived suppressor cells in transplantation. Curr Opin Organ Transplant 2010, 15:765-768.
34. Suzuki J., Ricordi C., Chen Z. Immune tolerance induction by integrating innate and adaptive immune regulators. Cell Transplant 2010, 19:253-268.
35. Rodriguez-Garcia M., Boros P., Bromberg J.S., Ochando J.C. Immunotherapy with myeloid cells for tolerance induction. Curr Opin Organ Transplant 2010, 15:416-421.
36. Adeegbe D., Serafini P., Bronte V., Zoso A., Ricordi C., Inverardi L. In vivo induction of myeloid suppressor cells and CD4+Foxp3+T regulatory cells prolongs skin allograft survival in mice. Cell Transplant 2011, 20:941-954.
37. Sinha P., Chornoguz O., Clements V.K., Artemenko K.A., Zubarev R.A., Ostrand-Rosenberg S. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 2011, 117:5381-5390.
38. Yin B., Ma G., Yen C.Y., Zhou Z., Wang G.X., Divino C.M., Casares S., Chen S.H., Yang W.C., Pan P.Y. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol 2010, 185:5828-5834.
39. Ribechini E., Greifenberg V., Sandwick S., Lutz M.B. Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol 2010, 199:273-281.
40. Zhou Z., French D.L., Ma G., Eisenstein S., Chen Y., Divino C.M., Keller G., Chen S.H., Pan P.Y. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 2010, 28:620-632.
41. Pastula A., Marcinkiewicz J. Myeloid-derived suppressor cells: a double-edged sword?. Int J Exp Pathol 2011, 92:73-78.